Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Beyer, J."'
Autor:
Beyer J, Lorch A, Bascoul-Mollevi C, Kramar A, Einhorn LH, Necchi A, Massard C, De Giorgi U, Flechon A, Margolin KA, Lotz JP, Lluch JRG, Powles T, Kollmannsberger CK
Publikováno v:
Journal of Clinical Oncology. 28:4906-4911
Purpose To develop a prognostic model in patients with germ cell tumors (GCT) who experience treatment failure with cisplatin-based first-line chemotherapy. Patients and Methods Data from 1,984 patients with GCT who progressed after at least three ci
Autor:
Konstantinos Koutsoukos, Carl W. Langberg, Jonathan Shamash, Matthew Wheater, Jeff White, Olof Ståhl, Torgrim Tandstad, Constance Thibault, Anis A. Hamid, Jorge Aparicio, Christian D. Fankhauser, Costantine Albany, Marcus Hentrich, Carsten Bokemeyer, Bruno Vincenzi, Jörg Beyer, Angelika Terbuch, Axel Heidenreich, Gabriella Cohn-Cedermark, Stefanie Fischer, Anja Lorch, Andrea Necchi, Dirk Klingbiel, Silke Gillessen
Publikováno v:
J Clin Oncol
PURPOSE Clinical stage I (CSI) nonseminoma (NS) is a disease limited to the testis without metastases. One treatment strategy after orchiectomy is adjuvant chemotherapy. Little is known about the outcome of patients who experience relapse after such
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c667edd1dd731f532fcdb98c9dc4d9c
Autor:
Anja Lorch, Patrizia Giannatempo, Eric Winquist, Darren R. Feldman, Peter Chung, Aude Flechon, Robert Huddart, Ugo De Giorgi, Jorge Aparicio, Christopher Sweeney, Lawrence H. Einhorn, Costantine Albany, Teodoro Sava, Thomas Powles, Jörg Beyer, Alexey Tryakin, Gabriella Cohn Cedermark, Helen Boyle, Andrea Necchi, Andrew Kramar, Carsten Bokemeyer
Publikováno v:
Journal of Clinical Oncology. 34:345-351
Purpose To define characteristics, treatment response, and outcomes of men with brain metastases (BM) from germ cell tumors (GCT). Patients and Methods Data from 523 men with BM from GCT were collected retrospectively from 46 centers in 13 countries
Autor:
Jose Ramon Germa-Lluch, Jörg Beyer, Jean Pierre Lotz, Aude Flechon, Christophe Massard, Lawrence H. Einhorn, Caroline Bascoul-Mollevi, Andrea Necchi, Christian Kollmannsberger, Andrew Kramar, Anja Lorch, Ugo De Giorgi, Kim Margolin, Thomas Powles
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 29(16)
Purpose Conventional-dose chemotherapy (CDCT) and high-dose chemotherapy (HDCT) may both be successfully used as salvage treatment for patients with metastatic germ cell tumors (GCTs) who experience progression with first-line treatment. Patients and